Unknown

Dataset Information

0

Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.


ABSTRACT: We demonstrated that intranasal granulocyte-macrophage colony-stimulating factor given to immunosuppressed mice infected with pulmonary aspergillosis resulted in a sixfold reduction in the lung fungal burden compared to the result for saline-treated mice (P = 0.045). These data suggest that lung-targeted immunotherapy may be complementary to antifungal agents and may improve patient responses.

SUBMITTER: Quezada G 

PROVIDER: S-EPMC2224773 | biostudies-literature | 2008 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.

Quezada Gerardo G   Koshkina Nadezhda V NV   Zweidler-McKay Patrick P   Zhou Zichao Z   Kontoyiannis Dimitrios P DP   Kleinerman Eugenie S ES  

Antimicrobial agents and chemotherapy 20071105 2


We demonstrated that intranasal granulocyte-macrophage colony-stimulating factor given to immunosuppressed mice infected with pulmonary aspergillosis resulted in a sixfold reduction in the lung fungal burden compared to the result for saline-treated mice (P = 0.045). These data suggest that lung-targeted immunotherapy may be complementary to antifungal agents and may improve patient responses. ...[more]

Similar Datasets

| S-EPMC4596277 | biostudies-literature
| S-EPMC10127946 | biostudies-literature
| S-EPMC5916331 | biostudies-literature
| S-EPMC3852053 | biostudies-literature
| S-EPMC3707315 | biostudies-literature
| S-EPMC5926922 | biostudies-literature
| S-EPMC404575 | biostudies-literature
| S-EPMC3014056 | biostudies-literature
| S-EPMC6534644 | biostudies-literature